Therefore, it is time to monitor the dynamic process of sHLA-G and cytokines in patients with cervical cancer, especially in the context of an excessive inflammatory response, such as cytokines storm observed after CAR-T cells’ therapy. This evidence concerns the gene HLA-G and cervical cancer.